10-Q 1 d400369d10q.htm 10-Q 10-Q
Table of Contents
falseQ3--12-310001840463NY 0001840463 2022-01-01 2022-09-30 0001840463 2021-12-31 0001840463 2022-09-30 0001840463 2021-01-05 2021-09-30 0001840463 2021-07-01 2021-09-30 0001840463 2022-07-01 2022-09-30 0001840463 2022-04-01 2022-06-30 0001840463 2021-01-05 2021-03-31 0001840463 2021-09-30 0001840463 2021-02-10 0001840463 2021-01-08 0001840463 2021-03-08 2021-03-08 0001840463 2021-04-01 2021-06-30 0001840463 2022-01-01 2022-03-31 0001840463 2021-01-04 0001840463 2021-06-30 0001840463 2021-03-31 0001840463 2022-06-30 0001840463 2022-03-31 0001840463 us-gaap:CommonClassBMember 2022-09-30 0001840463 us-gaap:CommonClassAMember 2022-09-30 0001840463 rxra:PrivateWarrantsMember 2022-09-30 0001840463 rxra:PublicWarrantsMember 2022-09-30 0001840463 rxra:PublicWarrantsMember us-gaap:CommonClassAMember 2022-09-30 0001840463 rxra:PrivateWarrantsMember us-gaap:CommonClassAMember rxra:ProspectiveWarrantRedemptionMember srt:MinimumMember 2022-09-30 0001840463 rxra:PrivateWarrantsMember us-gaap:CommonClassAMember rxra:ProspectiveWarrantRedemptionMember srt:MaximumMember 2022-09-30 0001840463 rxra:PrivateWarrantsMember us-gaap:CommonClassAMember rxra:ProspectiveWarrantRedemptionMember rxra:RedemptionTriggerPriceTwoMember 2022-09-30 0001840463 rxra:PublicWarrantsMember us-gaap:CommonClassAMember rxra:ProspectiveWarrantRedemptionMember rxra:RedemptionTriggerPriceTwoMember 2022-09-30 0001840463 rxra:PublicWarrantsMember us-gaap:CommonClassAMember rxra:ProspectiveWarrantRedemptionMember rxra:RedemptionTriggerPriceOneMember 2022-09-30 0001840463 rxra:InvestmentsHeldInTrustMoneyMarketFundMember us-gaap:FairValueInputsLevel1Member 2022-09-30 0001840463 rxra:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member 2022-09-30 0001840463 rxra:PrivateWarrantsMember us-gaap:FairValueInputsLevel2Member 2022-09-30 0001840463 us-gaap:FairValueInputsLevel3Member rxra:NotePayableRelatedPartyMember 2022-09-30 0001840463 rxra:PubilcWarrantMember us-gaap:CommonClassAMember 2022-09-30 0001840463 rxra:IPOAndPrivatePlacementMember 2022-09-30 0001840463 rxra:PrivatePlacementWarrantMember 2022-09-30 0001840463 us-gaap:IPOMember 2022-09-30 0001840463 rxra:PrivatePlacementWarrantsMember 2022-09-30 0001840463 us-gaap:CommonClassBMember rxra:FounderMember 2022-09-30 0001840463 rxra:SponsorMember rxra:PostIpoPromissoryNoteMember 2022-09-30 0001840463 us-gaap:CommonClassBMember 2021-12-31 0001840463 us-gaap:CommonClassAMember 2021-12-31 0001840463 rxra:InvestmentsHeldInTrustMoneyMarketFundMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001840463 rxra:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001840463 rxra:PrivateWarrantsMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001840463 us-gaap:CapitalUnitsMember 2022-01-01 2022-09-30 0001840463 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001840463 rxra:AfterInitialPublicOfferMember us-gaap:CommonClassAMember rxra:PublicWarrantsMember 2022-01-01 2022-09-30 0001840463 rxra:AfterBusinessCombinationMember us-gaap:CommonClassAMember rxra:PublicWarrantsMember 2022-01-01 2022-09-30 0001840463 rxra:PublicWarrantsMember us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001840463 rxra:PublicWarrantsMember us-gaap:CommonClassAMember rxra:ProspectiveWarrantRedemptionMember 2022-01-01 2022-09-30 0001840463 rxra:PrivateWarrantsMember us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001840463 rxra:PublicWarrantsMember rxra:ProspectiveWarrantRedemptionMember us-gaap:CommonClassAMember rxra:RedemptionTriggerPriceOneMember 2022-01-01 2022-09-30 0001840463 rxra:PublicWarrantsMember us-gaap:CommonClassAMember rxra:ProspectiveWarrantRedemptionMember rxra:RedemptionTriggerPriceTwoMember 2022-01-01 2022-09-30 0001840463 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001840463 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001840463 rxra:PrivateAndPublicWarrantsMember 2022-01-01 2022-09-30 0001840463 us-gaap:OverAllotmentOptionMember 2022-01-01 2022-09-30 0001840463 rxra:PrivatePlacementWarrantMember 2022-01-01 2022-09-30 0001840463 rxra:IPOAndPrivatePlacementMember 2022-01-01 2022-09-30 0001840463 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001840463 us-gaap:IPOMember 2022-01-01 2022-09-30 0001840463 rxra:SponsorMember rxra:PrivatePlacementWarrantMember 2022-01-01 2022-09-30 0001840463 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001840463 us-gaap:IPOMember 2021-03-08 2021-03-08 0001840463 us-gaap:IPOMember 2021-03-08 0001840463 us-gaap:OverAllotmentOptionMember 2021-03-16 2021-03-16 0001840463 us-gaap:OverAllotmentOptionMember 2021-03-16 0001840463 rxra:ClassACommonStockSubjectToPossibleRedemptionMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001840463 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001840463 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001840463 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001840463 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001840463 us-gaap:CommonClassAMember 2021-07-01 2021-09-30 0001840463 us-gaap:CommonClassBMember 2021-07-01 2021-09-30 0001840463 rxra:PublicWarrantsMember 2021-07-01 2021-09-30 0001840463 rxra:PrivatePlacementWarrantsMember 2021-07-01 2021-09-30 0001840463 us-gaap:CommonClassAMember 2021-01-05 2021-09-30 0001840463 us-gaap:CommonClassBMember 2021-01-05 2021-09-30 0001840463 us-gaap:CommonClassBMember 2021-01-08 2021-01-08 0001840463 us-gaap:CommonClassBMember 2021-01-08 0001840463 us-gaap:CommonClassBMember rxra:FounderMember 2021-03-03 0001840463 rxra:SponsorMember rxra:PostIpoPromissoryNoteMember 2022-05-10 0001840463 rxra:PrivateAndPublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-03-03 2021-03-31 0001840463 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001840463 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001840463 us-gaap:CommonStockMember rxra:ClassACommonStockSubjectToPossibleRedemptionMember 2022-04-01 2022-06-30 0001840463 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001840463 us-gaap:AdditionalPaidInCapitalMember 2021-01-05 2021-03-31 0001840463 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-01-05 2021-03-31 0001840463 us-gaap:CommonStockMember rxra:ClassACommonStockSubjectToPossibleRedemptionMember 2021-01-05 2021-03-31 0001840463 us-gaap:RetainedEarningsMember 2021-01-05 2021-03-31 0001840463 rxra:PostIpoPromissoryNoteMember rxra:SponsorMember 2022-05-10 2022-05-10 0001840463 rxra:InflationReductionActOf2022Member rxra:OnOrAfterJanuaryonetwoThousandAndTwentyThreeMember 2022-08-16 2022-08-16 0001840463 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001840463 us-gaap:CommonClassAMember 2022-11-09 0001840463 us-gaap:CommonClassBMember 2022-11-09 0001840463 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001840463 us-gaap:FairValueInputsLevel3Member 2022-09-30 0001840463 us-gaap:CommonStockMember rxra:ClassACommonStockSubjectToPossibleRedemptionMember 2022-09-30 0001840463 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-09-30 0001840463 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001840463 us-gaap:RetainedEarningsMember 2022-09-30 0001840463 rxra:ClassACommonStockSubjectToPossibleRedemptionMember us-gaap:CommonStockMember 2021-09-30 0001840463 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-09-30 0001840463 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001840463 us-gaap:RetainedEarningsMember 2021-09-30 0001840463 rxra:PrivateAndPublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-09-30 0001840463 us-gaap:FairValueInputsLevel3Member rxra:PrivateAndPublicWarrantsMember 2021-03-02 0001840463 rxra:PrivateAndPublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001840463 us-gaap:RetainedEarningsMember 2021-06-30 0001840463 rxra:ClassACommonStockSubjectToPossibleRedemptionMember us-gaap:CommonStockMember 2021-06-30 0001840463 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001840463 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-06-30 0001840463 us-gaap:RetainedEarningsMember 2021-12-31 0001840463 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001840463 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-12-31 0001840463 us-gaap:CommonStockMember rxra:ClassACommonStockSubjectToPossibleRedemptionMember 2021-12-31 0001840463 us-gaap:RetainedEarningsMember 2022-03-31 0001840463 us-gaap:CommonStockMember rxra:ClassACommonStockSubjectToPossibleRedemptionMember 2022-03-31 0001840463 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-03-31 0001840463 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001840463 us-gaap:RetainedEarningsMember 2022-06-30 0001840463 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001840463 rxra:ClassACommonStockSubjectToPossibleRedemptionMember us-gaap:CommonStockMember 2022-06-30 0001840463 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001840463 us-gaap:RetainedEarningsMember 2021-01-04 0001840463 us-gaap:AdditionalPaidInCapitalMember 2021-01-04 0001840463 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-01-04 0001840463 us-gaap:CommonStockMember rxra:ClassACommonStockSubjectToPossibleRedemptionMember 2021-01-04 0001840463 us-gaap:CommonStockMember rxra:ClassACommonStockSubjectToPossibleRedemptionMember 2021-03-31 0001840463 us-gaap:RetainedEarningsMember 2021-03-31 0001840463 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-03-31 iso4217:USD xbrli:shares utr:Month utr:Day xbrli:pure utr:Year iso4217:USD xbrli:shares
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2022
OR
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
                    
 to
                    
 
 
RXR ACQUISITION CORP.
(Exact name of registrant as specified in its charter)    
 
 
 
Delaware
 
001-40148
 
86-1258996
(State or other jurisdiction of
incorporation or organization)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
625 RXR Plaza
Uniondale,
NY
 
11556
(Address Of Principal Executive Offices)
 
(Zip Code)
(516)
506-6797
Registrant’s telephone number, including area code
Not Applicable
(Former name or former address, if changed since last report)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Units, each consisting of one share of Class A common stock, $0.0001 par value, and
one-fifth
of one redeemable warrant
 
RXRAU
 
The Nasdaq Capital Market LLC
Class A common stock included as part of the units
 
RXRA
 
The Nasdaq Capital Market LLC
Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
 
RXRAW
 
The Nasdaq Capital Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☐    No  ☒
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer      Accelerated filer  
Non-accelerated
filer
     Smaller reporting company  
     Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes      No  ☐
As of November
9
, 2022, 34,500,000 shares of Class A common stock, par value $0.0001 per share, and 8,625,000 shares of Class B common stock, par value $0.0001 per share, were issued and outstanding, respectively.
 
 
 


Table of Contents

RXR ACQUISITION CORP.

Quarterly Report on Form 10-Q

For the Quarter Ended September 30, 2022

 

PART I. FINANCIAL INFORMATION

  

Item 1.

   Financial Statements (Unaudited)      1  
   Condensed Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021      1  
   Unaudited Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2022, the three months ended September 30, 2021 and the period from January 5, 2021 (inception) through September 30, 2021 (Unaudited)      2  
   Unaudited Condensed Statements of Changes in Class A Common Stock Subject to Possible Redemption and Stockholders’ Equity (Deficit) for the Three and Nine Months Ended September 30, 2022, the three months ended September 30, 2021 and the period from January 5, 2021 (inception) through September 30, 2021 (Unaudited)      3  
   Unaudited Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2022 and the period from January 5, 2021 (inception) through September 30, 2021 (Unaudited)      4  
   Notes to Unaudited Condensed Financial Statements      5  

Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations      20  

Item 3.

   Quantitative and Qualitative Disclosures About Market Risk      24  

Item 4.

   Controls and Procedures      24  

PART II. OTHER INFORMATION

  

Item 1.

   Legal Proceedings      25  

Item 1A.

   Risk Factors      25  

Item 2.

   Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities      26  

Item 3.

   Defaults Upon Senior Securities      26  

Item 4.

   Mine Safety Disclosures      26  

Item 5.

   Other Information      26  

Item 6.

   Exhibits      27  


Table of Contents
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
RXR ACQUISITION CORP.
CONDENSED BALANCE SHEETS
 
    
September 30,
2022
   
December 31,
2021
 
    
(Unaudited)
 
Assets:
                
Current assets:
                
Cash
   $ 92,810     $ 195,671  
Prepaid expenses
     154,832       368,665  
    
 
 
   
 
 
 
Total current assets
     247,642       564,336  
Investments held in Trust Account
     346,811,125       345,021,006  
    
 
 
   
 
 
 
Total Assets
  
$
347,058,767
 
 
$
345,585,342
 
    
 
 
   
 
 
 
Liabilities and Stockholders’ Deficit:
                
Current liabilities:
                
Accounts payable and accrued expenses
   $ 12,261     $ 161,372  
Income tax payable
     451,591     $     
Franchise tax payable
     49,815       200,000  
Note payable - related party
     450,000           
    
 
 
   
 
 
 
Total current liabilities
     963,667       361,372  
Derivative warrant liabilities
     384,750       8,991,820  
Deferred underwriting commissions
     12,075,000       12,075,000  
    
 
 
   
 
 
 
Total Liabilities
     13,423,417       21,428,192  
    
 
 
   
 
 
 
Commitments and Contingencies
                
     
Class A common stock, $0.0001 par value; 250,000,000 shares authorized; 34,500,000 shares issued and outstanding, subject to possible redemption at $10.034 and $10.000 per share as of September 30, 2022 and December 31, 2021, respectively
     346,176,325       345,000,000  
     
Stockholders’ Deficit:
                
Preferred stock, $0.0001 par value; 2,500,000 shares authorized; none issued and outstanding as of September 30, 2022 and December 31, 2021
                  
Class B common stock, $0.0001 par value; 25,000,000 shares authorized; 8,625,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021
     863       863  
Additional
paid-in
capital
                  
Accumulated deficit
     (12,541,838     (20,843,713
    
 
 
   
 
 
 
Total stockholders’ deficit
     (12,540,975     (20,842,850
    
 
 
   
 
 
 
Total Liabilities and Stockholders’ Deficit
  
$
347,058,767
 
 
$
345,585,342
 
    
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
1

RXR ACQUISITION CORP.
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS
 
   
For The Three Months
Ended September 30, 2022
   
For The Three Months
Ended September 30, 2021
   
For The Nine Months
Ended September 30, 2022
   
For The Period From January 5, 2021
(Inception) Through September 30, 2021
 
General and administrative expenses
  $ 146,735     $ 352,768     $ 494,189     $ 706,057  
General and administrative expenses - related party
    30,000       30,000       90,000       69,032  
Franchise tax expenses
    50,000       49,863       117,025       147,447  
   
 
 
   
 
 
   
 
 
   
 
 
 
Loss from operations
    (226,735     (432,631     (701,214     (922,536
   
 
 
   
 
 
   
 
 
   
 
 
 
Other income (expense)
                               
Change in fair value of derivative warrant liabilities
    1,576,050       3,593,330       8,607,070       4,037,670  
Offering costs associated with derivative warrant liabilities
                               (424,230
Income from investments held in Trust Account
    1,616,952       6,403       2,023,935       13,678  
   
 
 
   
 
 
   
 
 
   
 
 
 
Total other income (expense), net
    3,193,002       3,599,733       10,631,005       3,627,118  
   
 
 
   
 
 
   
 
 
   
 
 
 
Net income before income taxes
    2,966,267       3,167,102       9,929,791       2,704,582  
Income tax expense
    (400,332              (451,591         
   
 
 
   
 
 
   
 
 
   
 
 
 
Net income allocable to common stockholders
  $ 2,565,935     $ 3,167,102     $ 9,478,200     $ 2,704,582  
   
 
 
   
 
 
   
 
 
   
 
 
 
Weighted average shares outstanding of Class A common stock
    34,500,000       34,500,000       34,500,000       34,326,087  
   
 
 
   
 
 
   
 
 
   
 
 
 
Basic and diluted net income (loss) per share, Class A
  $ 0.03     $ 0.07     $ 0.19     $ (0.62
   
 
 
   
 
 
   
 
 
   
 
 
 
Weighted average shares outstanding of Class B common stock
    8,625,000       8,625,000       8,625,000       8,341,635  
   
 
 
   
 
 
   
 
 
   
 
 
 
Basic and diluted net income (loss) per share, Class B
  $ 0.03     $ 0.07     $ 0.19     $ (0.62
   
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
2

RXR ACQUISITION CORP.
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN CLASS A COMMON STOCK SUBJECT
TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ EQUITY (DEFICIT)
Three months and nine ended September 30, 2022
 
               
Stockholders’ Deficit
 
   
Class A Common Stock
subject to possible redemption
   
Class B Common Stock
   
Additional Paid-In

Capital
   
Accumulated

Deficit
   
Total
Stockholders’

Deficit
 
   
Shares
   
Amount
   
Shares
   
Amount
 
Balance - December 31, 2021
 
 
34,500,000
 
 
$
345,000,000
 
 
 
8,625,000
 
 
$
863
 
 
$
—  
 
 
$
(20,843,713
 
$
(20,842,850.00
Net income
    —         —         —         —         —         2,944,695       2,944,695  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance - March 31, 2022
 
 
34,500,000
 
 
 
345,000,000
 
 
 
8,625,000
 
 
 
863
 
 
 
—  
 
 
 
(17,899,018
 
 
(17,898,155
Deemed dividend - increase in redemption value of Class A common stock subject to possible redemption
    —         9,706       —         —         —         (9,706     (9,706
Net income
    —         —         —         —         —         3,967,570       3,967,570  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance - June 30, 2022
 
 
34,500,000
 
 
 
345,009,706
 
 
 
8,625,000
 
 
 
863
 
 
 
—  
 
 
 
(13,941,154
 
 
(13,940,291
Deemed dividend - increase in redemption value of Class A common stock subject to possible redemption
    —         1,166,619       —         —         —         (1,166,619     (1,166,619
Net income
    —         —         —         —         —         2,565,935       2,565,935  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance - September 30, 2022
 
 
34,500,000
 
 
$
346,176,325
 
 
 
8,625,000
 
 
$
863
 
 
$
  
 
 
$
(12,541,838
 
$
(12,540,975
)  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
For the three months ended September 30, 2021 and for the period from January 5, 2021 (inception) through September 30, 2021
 
               
Stockholders’ Equity (Deficit)
 
   
Class A Common Stock
subject to possible redemption
   
Class B Common Stock
   
Additional Paid-In

Capital
   
Accumulated

Deficit
   
Total
Stockholders’

Equity (Deficit)
 
   
Shares
   
Amount
   
Shares
   
Amount
 
Balance - January 5, 2021 (inception)
 
 
—  
 
 
$
—  
 
 
 
—  
 
 
$
—  
 
 
$
—  
 
 
$
—  
 
 
$
—  
 
Issuance of Class B common stock to Sponsor
    —         —         8,625,000       863       24,137       —         25,000  
Sale of units in initial public offering,less allocation to derivative warrant liabilities, gross
    34,500,000       337,686,000       —         —         —         —         —    
Offering costs
    —         (19,106,790     —         —         —         —         —    
Excess cash received over the fair value of private placement warrants
    —         —         —         —         2,551,330       —         2,551,330  
Deemed dividend to Class A stockholders
    —         26,420,790       —         —         (2,575,467     (23,845,323     (26,420,790
Net income
    —         —         —         —         —         476,332       476,332  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance - March 31, 2021
 
 
34,500,000
 
 
 
345,000,000
 
 
 
8,625,000
 
 
 
863
 
 
 
—  
 
 
 
(23,368,991
 
 
(23,368,128
Net loss
    —         —         —         —         —         (938,852     (938,852
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance - June 30, 2021
 
 
34,500,000
 
 
 
345,000,000
 
 
 
8,625,000
 
 
 
863
 
 
 
  
 
 
 
(24,307,843
 
 
(24,306,980
Net income
    —         —         —         —         —         3,167,102       3,167,102  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance - September 30, 2021
 
 
34,500,000
 
 
$
345,000,000
 
 
 
8,625,000
 
 
$
863
 
 
$
  
 
 
$
(21,140,741
 
$
(21,139,878
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
3

RXR ACQUISITION CORP.
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS
 
    
For The Nine Months
Ended September 30,
2022
   
For The Period From January 5, 2021
(Inception) Through September 30,
2021
 
Cash Flows from Operating Activities:
                
Net income
   $ 9,478,200     $ 2,704,582  
Adjustments to reconcile net income to net cash used in operating activities:
                
Change in fair value of derivative warrant liabilities
     (8,607,070     (4,037,670
Offering costs associated with derivative warrant liabilities
              424,230  
Income from investments held in Trust Account
     (2,023,935     (13,678
Changes in operating assets and liabilities:
                
Prepaid expenses
     213,833       (451,039
Accounts payable and accrued expenses
     (149,111     223,863  
Income tax payable
     451,591           
Franchise tax payable
     (150,185     147,447  
    
 
 
   
 
 
 
Net cash used in operating activities
     (786,677     (1,002,265
    
 
 
   
 
 
 
Cash Flows from Investing Activities:
                
Investment income released from Trust Account to pay for franchise taxes
     233,816           
Cash deposited in Trust Account
              (345,000,000
    
 
 
   
 
 
 
Net cash provided by (used in) investing activities
     233,816       (345,000,000
    
 
 
   
 
 
 
Cash Flows from Financing Activities:
                
Proceeds from issuance of Class B common stock to Sponsor
              25,000  
Borrowings under note payable with related party
     450,000       150,000  
Repayment of note payable to related party
              (150,000
Proceeds received from initial public offering, gross
              345,000,000  
Proceeds received from private placement
              8,900,000  
Offering costs paid
              (7,386,020
    
 
 
   
 
 
 
Net cash provided by financing activities
     450,000       346,538,980  
    
 
 
   
 
 
 
Net change in cash
     (102,861     536,715  
Cash - beginning of the period
     195,671           
    
 
 
   
 
 
 
Cash - end of the period
  
$
92,810
 
 
$
536,715
 
    
 
 
   
 
 
 
Supplemental disclosure of noncash activities:
                
Offering costs included in accrued expenses
   $        $ 70,000  
Deferred underwriting commissions
   $        $ 12,075,000  
Deemed dividend to Class A stockholders
   $ 1,176,325     $ 26,420,790  
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
4

RXR ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Note
1-Description
of Organization and Business Operations
RXR Acquisition Corp. (the “Company”) is a blank check company incorporated in Delaware on January 5, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. The Company’s sponsor is RXR Acquisition Sponsor LLC, a Delaware limited liability company (the “Sponsor”).
As of September 30, 2022, the Company had not commenced any operations. Substantially, all activity for the period from January 5, 2021 (inception) through September 30, 2022 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”), and activities related to the pursuit of a target described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates
non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering.
The registration statement for the Company’s Initial Public Offering was declared effective on March 3, 2021. On March 8, 2021, the Company consummated its Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.1 million, of which $10.5 million was for deferred underwriting commissions (Note 4). The Company granted the underwriters a
45-day
option to purchase up to an additional 4,500,000 Units at the Initial Public Offering price to cover over -allotments, if any. The underwriters exercised the over-allotment option in full on March 16, 2021, purchasing an additional 4,500,000 Units (the “Over-Allotment Units”) and generating gross proceeds of $45.0 million. The Company incurred additional offering costs of approximately $2.5 million, of which approximately $1.6 million was for deferred underwriting commissions.
Each Unit consists of one share of Class A common stock and
one-fifth
of one redeemable warrant (each redeemable warrant, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 5). Such shares of Class A common stock and Public Warrants may trade as separate financial instruments.
Simultaneous with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 5,333,333 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant to the Sponsor, generating proceeds of $8.0 million (Note 3). Simultaneous with the closing of the sale of Over-Allotment Units, the Company consummated the second closing of the Private Placement, resulting in the purchase of an additional 600,000 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of $900,000.
Upon the closing of the Initial Public Offering, the sale of Over-Allotment Units and the Private Placement, $345.0 million ($10.00 per Unit) of net proceeds of the Initial Public Offering, the Sale of Over-Allotment Units and the Private Placement were placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. “government securities,” within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule
2a-7
promulgated under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the trust
 
5

RXR ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
account) at the time of the agreement to enter into the initial Business Combination. However, the Company only intends to complete a Business Combination if the post-transaction company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
The Company will provide the holders of the Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially anticipated to be $10.00 per Public Share). The
per-share
amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 4). These Public Shares are accounted for at their redemption value and have been classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”). If the Company seeks stockholder approval, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. The Company will not redeem the Public Shares in connection with a Business Combination in an amount that would cause its net tangible assets to be less than $5,000,001 (as prescribed by exchange listing standards). If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem the Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the Initial Stockholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 3) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Stockholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.
The Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company.
The holders of the Founder Shares (the “Initial Stockholders”) agreed not to propose an amendment to the Certificate of Incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B) with respect to any other provision relating to stockholders’ rights or
pre-initial
Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or March 8, 2023 (the “Combination Period”), and the Company’s stockholders have not amended the Certificate of Incorporation to extend such Combination Period, the Company will (1) cease all operations except for the purpose of winding up; (2) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any); and (3) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
 
6

RXR ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
The Initial Stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 4) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement (a “Target”), reduce the amount of funds in the Trust Account to below (i) $10.00 per Public Share or (ii) the lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of interest which may be withdrawn to pay taxes, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Note
2-Basis
of Presentation and Summary of Significant Accounting Policies
Basis of Presentation
The accompanying condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 10 of Regulation
S-X.
Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these condensed financial statements as they are not required for interim financial statements under GAAP and the rules of the SEC. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form
10-K
for the year ended December 31, 2021, as filed with the SEC on March 21, 2022, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2021, is derived from the audited financial statements presented in the Company’s Annual Report on Form
10-K
for the year ended December 31, 2021, as filed with the SEC on March 21, 2022.
Liquidity and Going Concern
As of September 30, 2022, the Company had approximately $93,000 in cash and working capital deficit of approximately $215,000 (not taking into account tax obligations of approximately $501,000 that may be paid using investment income earned in the Trust Account).
The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to purchase Founder Shares (as defined in Note 3), and loan proceeds from the
 
7

RXR ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Sponsor of $150,000 under the Note (as defined in Note 3). The Company repaid the Note in full on March 8, 2021. After closing the Initial Public Offering, the Company’s liquidity needs have been satisfied through the net proceeds from the consummation of the Initial Public Offering, the sale of Over-Allotment Units and the Private Placement held outside of the Trust Account, and from borrowings under a promissory note issued to the Sponsor.
In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic
205-40,
“Presentation of Financial Statements-Going Concern,” management has evaluated the Company’s liquidity and financial condition and determined that it may not be sufficient to meet the Company’s obligation over the period of twelve months from the issuance date of the financial statements. The Company’s sponsor has agreed to provide support to enable the Company to continue its operations and meet its potential obligations over a period of one year from the issuance date of these financial statements. Management believes current working capital, and the support from its Sponsor, provides sufficient capital to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of those financial statements and therefore substantial doubt has been alleviated.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements. Actual results could differ from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents held outside of the Trust Account as of September 30, 2022 and December 31, 2021.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of September 30, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
 
8

RXR ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Investments Held in Trust Account
The Company’s portfolio of investments held in the Trust Account is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. Such securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in the Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements” approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature.
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
   
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
   
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
   
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Offering Costs Associated with the Initial Public Offering
Offering costs consist of legal, accounting, underwriting and other costs incurred that were directly related to the Initial Public Offering, the sale of Over-Allotment Units and the Private Placement. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering, the sale of Over-Allotment Units and the Private Placement based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred and presented as
non-operating
expenses in the condensed statements of operations. Offering costs associated with the Public Shares were charged to the carrying value of the Class A common stock, classified in temporary equity, upon the completion of the Initial Public Offering and sale of Over-Allotment Units.
 
9

RXR ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Derivative Warrant Liabilities and Class A Common Shares Subject to Possible Redemption
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be accounted for as liabilities or as equity, is
re-assessed
at the end of each reporting period.
The 6,900,000 Public Warrants issued in connection with the Initial Public Offering and sale of Over-Allotment Units and the 5,933,333 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed statements of operations. The initial fair value of the Public Warrants and Private Placement Warrants were estimated using a Monte Carlo simulation model. The fair value of the Public Warrants and Private Placement Warrants have subsequently been measured based on the listed market price of the Public Warrants or inputs derived from the Public Warrants. Derivative warrant liabilities are classified as
non-current
liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of September 30, 2022 and December 31, 2021, 34,500,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A common stock subject to possible redemption to equal the redemption value at the end of each reporting period. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. Subsequent changes result from income and losses on investments held in the Trust Account that would be distributed to the Class A common stockholders upon redemption.
On April 12, 2021, the staff of the Securities and Exchange Commission (the “SEC Staff”) issued a public statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities on a SPAC’s balance sheet as opposed to equity. The Company presents its warrants as liabilities, with subsequent changes in fair value reported in the Company’s condensed statements of operations each reporting period. Additionally, the carrying value of Class A common stock is classified as temporary equity (at redemption value) on the Company’s condensed balance sheets.
Income Taxes
The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax laws and tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of September 30, 2022 and December 31, 2021, the Company had gross deferred tax assets of approximately $452,000 and $325,000, respectively, which are subject to a full valuation allowance.
 
10

RXR ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2022 and December 31, 2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company may be subject to potential examination by federal, state and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal, state and city tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is subject to income tax examinations by major taxing authorities since inception.
Net Income (Loss) per Common Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period as calculated using the treasury stock method. At September 30, 2022 and December 31, 2021, the Company had outstanding warrants to purchase up to 12,833,333 Class A common shares. The weighted average of these shares was excluded from the calculation of diluted net income (loss) per common share since the exercise of the warrants is contingent upon the occurrence of future events. As a result, diluted net income (loss) per common share is the same as basic net income (loss) per common share for the three and nine months ended September 30, 2022, the three months ended September 30, 2021 and the period from January 5, 2021 (inception) through September 30, 2021.
As of September 30, 2022 and 2021, the Company has two classes of common shares, Class A common shares and Class B common shares. For the three and nine months ended September 30, 2022, the three months ended September 30, 2021 and the period from January 5, 2021 (inception) through September 30, 2021, earnings and losses are adjusted for the effects of the excess cash received over the fair value of the Private Placement Warrants and deemed dividend to Class A stockholders and are allocated pro rata between the two classes of common shares as follows:
 
    
For The Three Months Ended September 30, 2022
    
For The Three Months Ended September 30, 2021
 
Basic and diluted net income per common share
     Class A        Class B        Class A        Class B  
Numerator:
                                   
Allocation of net income, as adjusted
   $ 1,119,453      $ 279,863      $ 2,533,682      $ 633,420  
Denominator:
                                   
Basic and diluted weighted average common shares outstanding
     34,500,000        8,625,000        34,500,000        8,625,000  
Basic and diluted net income, as adjusted, per common share
   $ 0.03      $ 0.03      $ 0.07      $ 0.07  
 
    
For The Nine Months Ended September 30, 2022
    
For The Period From January 5, 2021
(Inception) Through September 30, 2021
 
Basic and diluted net income per common share
     Class A        Class B        Class A       Class B  
Numerator:
                                  
Allocation of net income
   $ 6,641,500      $ 1,660,375      $ (21,132,175   $ (5,135,363
Denominator:
                                  
Basic and diluted weighted average common shares outstanding
     34,500,000        8,625,000        34,326,087       8,341,635  
Basic and diluted net income, as adjusted, per common share
   $ 0.19      $ 0.19      $ (0.62   $ (0.62
 
The following table sets for the reconciliation from net income (loss) as reported on the accompanying statement of operations to allocation of net income (loss) to the Class A and Class B common stockholders adjusted for the effects​​​​​​​
 
11

RXR ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
of the excess cash received over the fair value of the Private Placement Warrants and deemed dividend to Class A stockholders:
 
    
For The Three Months Ended

September 30, 2022
   
For The Three Months Ended
September 30, 2021
 
Net income as reported
   $ 2,565,935     $ 3,167,102  
Reconciliation Items:
                
Excess cash received over the fair value of private placement warrants
                  
Deemed dividend to Class A stockholders
     (1,166,619         
    
 
 
   
 
 
 
Allocation of net income, as adjusted
   $ 1,399,316     $ 3,167,102  
    
 
 
   
 
 
 
 
    
For The Nine Months Ended

September 30, 2022
   
For The Period From January 5, 2021

(Inception) Through September 30, 2021
 
Net income as reported
   $ 9,478,200     $ 2,704,582  
Reconciliation Items:
                
Excess cash received over the fair value of private placement warrants
              (2,551,330
Deemed dividend to Class A stockholders
     (1,176,325     (26,420,790
    
 
 
   
 
 
 
Allocation of net income (loss), as adjusted
   $ 8,301,875     $ (26,267,538
    
 
 
   
 
 
 
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements.
Note
3-Related
Party Transactions
Founder Shares
On January 8, 2021, the Sponsor paid $25,000 to the Company in exchange for issuance of 7,187,500 shares of the Company’s Class B common stock, par value $0.0001 per share, (the “Founder Shares”). On February 10, 2021, the Sponsor transferred 30,000 Founder Shares to each of the four independent director nominees. On March 3, 2021, the Company effected a stock dividend of 0.2 of a share of Class B common stock for each outstanding share of Class B common stock, resulting in an aggregate of 8,625,000 shares of Class B common stock outstanding.
The Initial Stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination; and (B) subsequent to the initial Business Combination (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any
20-trading
days within any
30-trading
day period commencing at least 150 days after the initial Business Combination or (y) the date on which the Company completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property. Any permitted transferees would be subject to the same restrictions and other agreements of the Initial Stockholders with respect to any Founder Shares.
Private Placement Warrants
Simultaneous with the closing of the Initial Public Offering, the Company consummated the Private Placement of 5,333,333 Private Placement Warrants at a price of $1.50 per Private Placement Warrant to the Sponsor, generating proceeds of $8.0 million. Simultaneous with the closing of the Over-Allotment Units on March 16, 2021, the Company consummated the second closing of the Private Placement, resulting in the purchase of an additional 600,000 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of $900,000.
 
12

RXR ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Each Private Placement Warrant is exercisable for one whole share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless.
The purchasers of the Private Placement Warrants agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants (except to permitted transferees) until 30 days after the completion of the initial Business Combination.
Related Party Loans
On January 8, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was
non-interest
bearing and due upon the completion of the Initial Public Offering. The Company borrowed $150,000 under the Note and repaid the Note in full on March 8, 2021.
On May 10, 2022, the Company entered into a promissory note with the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $1,500,000 (the
“Post-IPO
Promissory Note”). The
Post-IPO
Promissory Note is
non-interest
bearing and due on the earlier of March 8, 2023 or the date on which the Company consummates its Business Combination. If the Company completes a Business Combination, the Company would repay such additional loaned amounts, without interest, upon consummation of the business combination, or, at the option of the Sponsor, convert the principal amount of such
Post-IPO
Promissory Note into Private Placement Warrants based on a value of $1.50 per warrant. As of September 30, 2022, there was $450,000 outstanding under the
Post-IPO
Promissory Note. Such amount is recorded at fair value.
Administrative Services Agreement
Commencing on the date that the Company’s securities were first listed on Nasdaq through the earlier of consummation of the initial Business Combination and the Company’s liquidation, the Company agreed to pay an affiliate of the Sponsor a total of $10,000 per month for office space, administrative and support services. The Company incurred approximately $30,000 and $30,000 in related party general and administrative expenses in the accompanying condensed statements of operations for the three months ended September 30, 2022 and 2021. The Company incurred approximately $90,000 and $69,000 in related party general and administrative expenses in the accompanying condensed statements of operations for the nine months ended September 30, 2022 and 2021.
The Sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any
out-of-pocket
expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee reviews on a quarterly basis all payments that were made to the Sponsor, directors, officers or any of their affiliates.
Note
4-Commitments
and Contingencies
Registration Rights
The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares), are entitled to registration rights pursuant to a registration rights agreement signed upon the consummation of the Initial Public Offering. These holders are entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable
lock-up
period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
 
13

RXR ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Underwriting Agreement
The Company granted the underwriters a
45-day
option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price, less underwriting discounts and commissions. The underwriters exercised the over-allotment option in full and on March 16, 2021, purchasing an additional 4,500,000 Units.
The underwriters were entitled to an underwriting discount of $0.20 per Unit, or $6.9 million in the aggregate, which was paid upon the closing of the Initial Public Offering and sale of Over-Allotment Units. An additional fee of $0.35 per Unit, or approximately $12.1 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
Risks and Uncertainties
We continue to evaluate the impact of macroeconomic and socioeconomic events (including increased benchmark interest rates, inflation impacts, and continuing effects from the COVID-19 pandemic) and have concluded that the specific impact is not readily determinable as of the date of these condensed financial statements. The condensed financial statements do not include any adjustments that might result from such uncertainties.
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these condensed financial statements.
On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any share redemption or other share repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury.
The mechanics of any required payment of the excise tax have not been determined. The foregoing uncertainties could cause a reduction in the cash available on hand to complete a Business Combination and may impact the Company’s ability to successfully complete a Business Combination within the Combination Period.
Note
5-Derivative
Warrant Liabilities
As of September 30, 2022, the Company had an aggregate of 12,833,333 warrants outstanding, comprised of 6,900,000 Public Warrants and 5,933,333 Private Warrants outstanding.
Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the Public Warrants and a
 
14

RXR ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company agreed that as soon as practicable, but in no event later than 15 business days after the closing of its initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC and have an effective registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the Company’s initial Business Combination and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. If the shares issuable upon exercise of the warrants are not registered under the Securities Act in accordance with the above requirements, the Company will be required to permit holders to exercise their warrants on a cashless basis. However, no warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. Notwithstanding the above, if the Company’s shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
The warrants (collectively, the Public Warrants and the Private Placement Warrants) have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger prices described below under “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” and “Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below under “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.
The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be
non-redeemable
(except as described below in “Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00”) so long as they are held by the Sponsor or its permitted transferees. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00:
Once the warrants become exercisable, the Company may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants):
 
15

RXR ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
   
in whole and not in part;
 
   
at a price of $0.01 per warrant;
 
   
upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and
 
   
if, and only if, the last reported sale price of Class A common stock for any 20 trading days within a
30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted).
The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available throughout the
30-day
redemption period. If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00:
Once the warrants become exercisable, the Company may redeem the outstanding warrants:
 
   
in whole and not in part;
 
   
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” (as defined below) of Class A common stock;
 
   
if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted); and
 
   
if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants, as described above.
The “fair market value” of Class A common stock for the above purpose shall mean the volume weighted average price of Class A common stock during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 shares of Class A common stock per warrant (subject to adjustment).
If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
Note
6-Class
A Common Stock Subject to Possible Redemption
The Company is authorized to issue 250,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of September 30, 2022 and December 31, 2021, there were 34,500,000 shares of Class A common stock issued and outstanding, which are subject to possible redemption.
Holders of the Company’s Class A common stock have the opportunity to redeem all or a portion of their public shares upon the completion of the Initial Business Combination either (i) in connection with a stockholder meeting called to approve the business combination or (ii) without a stockholder vote by means of a tender offer. The decision as to
 
16

RXR ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
whether the Company will seek stockholder approval of a proposed business combination or conduct a tender offer will be made by the Company, solely in management’s discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek stockholder approval under applicable law or stock exchange listing requirement.
The Company’s amended and restated certificate of incorporation provides that in no event will the Company redeem its Class A common stock in an amount that would cause the Company’s net tangible assets to be less than $5,000,001 (as prescribed by exchange listing standards). In addition, the proposed Initial Business Combination may impose a minimum cash requirement for: (i) cash consideration to be paid to the target or its owners, (ii) cash for working capital or other general corporate purposes or (iii) the retention of cash to satisfy other conditions. In the event the aggregate cash consideration the Company would be required to pay for all shares of Class A common stock that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed Initial Business Combination exceed the aggregate amount of cash available to the Company, the Company will not complete the Initial Business Combination or redeem any shares in connection with such Initial Business Combination, and all shares of Class A common stock submitted for redemption will be returned to the holders thereof.
Note
7-Stockholders’
Deficit
Preferred Stock
-The Company is authorized to issue 2,500,000 shares of preferred stock, par value $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding.
Class
 B Common Stock
-The Company is authorized to issue 25,000,000 shares of Class B common stock with a par value of $0.0001 per share. As of September 30, 2022 and December 31, 2021, there were 8,625,000 share of Class B common stock outstanding. The Class B common stock will automatically convert into Class A common stock at the time of the initial Business Combination, or earlier at the option of the holder, on a
one-for-one
basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of the initial Business Combination, the ratio at which the shares of Class B common stock will convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the issued and outstanding shares of the Class B common stock agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an
as-converted
basis, 20% of the sum of all shares of common stock issued and outstanding upon the completion of the Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the initial Business Combination, excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination. Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders and vote together as a single class, except as required by law.
Note
8-Fair
Value Measurements
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.
 
    
September 30, 2022
 
Description
  
Quoted Prices in
Active Markets
(Level 1)
    
Significant Other
Observable Inputs
(Level 2)
    
Significant Other
Unobservable Inputs
(Level 3)
 
Assets:
                          
Investments held in Trust Account-Money market fund
   $ 346,811,125      $ —        $ —    
Liabilities:
                          
Derivative warrant liabilities-Public warrants
   $ 206,990      $ —        $ —    
Derivative warrant liabilities-Private placement warrants
   $ —        $ 177,760      $ —    
Note payable - related party
   $ —        $ —        $ 450,000  
 
17

RXR ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
    
December 31, 2021
 
Description
  
Quoted Prices
in
Active Markets
(Level 1)
    
Significant
Other
Observable
Inputs
(Level 2)
    
Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:
                          
Investments held in Trust Account-Money market fund
   $ 345,021,006      $ —        $ —    
Liabilities:
                          
Derivative warrant liabilities-Public warrants
   $ 4,831,580      $ —        $ —    
Derivative warrant liabilities-Private placement warrants
   $ —        $ 4,160,240      $ —    
Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants was transferred from a Level 3 measurement to a Level 1 measurement in the quarter ending June 30, 2021 as the Public Warrants were separately listed and traded in an active market during the period. The estimated fair value of the Private Placement Warrants was transferred from a Level 3 measurement to a Level 2 measurement in the quarter ending June 30, 2021, as all of the significant inputs to the valuation model used to estimate the fair value of the Private Placement Warrants became directly or indirectly observable from the listed Public Warrants. Level 1 assets include investments in money market funds.
For the three months ended September 30, 2022 and 2021, the Company recognized an unrealized gain/(loss) in the condensed statements of operations resulting from a decrease in the fair value of derivative warrant liabilities of approximately $1.6 million and $3.6 million, respectively.
For the nine months ended September 30, 2022 and for the period from January 5, 2021 (inception) through September 30, 2021, the Company recognized an unrealized gain/(loss) in the condensed statements of operations resulting from a decrease/(increase) in the fair value of derivative warrant liabilities of approximately $8.6 million and $4.0 million, respectively.
The fair value of the Note Payable was estimated using the market approach as management believes that fair value approximates the transaction price.
The initial fair value of the Public Warrants and Private Placement Warrants was estimated using a Monte Carlo simulation model. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s traded securities and from historical volatility of select peer company’s common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury
zero-coupon
yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.
The change in the fair value of the notes payable and derivative warrant liabilities, measured with Level 3 inputs, for the nine months ended September 30, 2022 and 2021, respectively is summarized as follows:
 
Note payable - related party at January 1, 2022
   $     
Borrowing from sponsor
     450,000  
    
 
 
 
Note payable - related party at September 30, 2022
   $ 450,000  
Derivative warrant liabilities at March 3, 2021 (inception)
   $     
Issuance of Public and Private Warrants
     13,662,670  
Change in fair value of derivative warrant liabilities
     (1,026,670
    
 
 
 
Derivative warrant liabilities at March 31, 2021
     12,636,000  
Transfer of Public Warrants to Level 1
     (6,762,000
Transfer of Private Placement Warrants to Level 2
     (5,874,000
    
 
 
 
Derivative warrant liabilities at September 30, 2021
   $     
    
 
 
 
 
18

RXR ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Note 9 - Subsequent Events
The Company evaluated subsequent events and transactions that occurred up to the date the condensed financial statements were issued. Based upon this review, the Company determined that there have been no events, except for the below, that have occurred that would require adjustments to the disclosures in the condensed financial statements.
 
19


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to the “Company,” “RXR Acquisition Corp.,” “RXR,” “our,” “us” or “we” refer to RXR Acquisition Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.

Overview

We are a blank check company incorporated in Delaware on January 5, 2021. We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies. Our sponsor is RXR Acquisition Sponsor LLC, a Delaware limited liability company (“Sponsor”).

The registration statement for our Initial Public Offering was declared effective on March 3, 2021.

On March 8, 2021, we consummated our Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.1 million, of which $10.5 million was for deferred underwriting commissions. We granted the underwriter a 45-day option to purchase up to an additional 4,500,000 Units at the Initial Public Offering price to cover over-allotments, if any. The underwriters exercised the over-allotment option in full on March 16, 2021, purchasing an additional 4,500,000 Units (the “Over-Allotment Units”), generating gross proceeds of $45.0 million. We incurred additional offering costs of approximately $2.5 million, of which approximately $1.6 million was for deferred underwriting commissions.

Each Unit consists of one share of Class A common stock and one-fifth of one redeemable warrant (each redeemable warrant, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment. Such shares of Class A common stock and Public Warrants may trade as separate financial instruments.

Simultaneous with the closing of the Initial Public Offering, we consummated the private placement (“Private Placement”) of 5,333,333 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant to the Sponsor, generating proceeds of $8.0 million. Simultaneous with the closing of the sale of Over-Allotment Units, we consummated the second closing of the Private Placement, resulting in the purchase of an aggregate of an additional 600,000 Private Placement Warrants by our Sponsor, generating gross proceeds to the Company of approximately $900,000.

Upon the closing of the Initial Public Offering, the sale of Over-Allotment Units and the Private Placement, $345.0 million ($10.00 per Unit) of net proceeds of the Initial Public Offering, the Sale of Over-Allotment Units and the Private Placement were placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. “government securities,” within the

 

20


Table of Contents

meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

Our management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that we will be able to complete a Business Combination successfully. We must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, we only intend to complete a Business Combination if the post-transaction company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.

If we are unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or March 8, 2023 (the “Combination Period”), and our stockholders have not amended the Certificate of Incorporation to extend such Combination Period, we will (1) cease all operations except for the purpose of winding up; (2) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any); and (3) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

Liquidity and Going Concern

As of September 30, 2022, we had approximately $93,000 in our operating bank account, and working capital of approximately $215,000 (not taking into account franchise tax obligations of $501,000 that may be paid using investment income earned in the Trust Account)

Our liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from our Sponsor to purchase Founder Shares (as defined below), and loan proceeds from our Sponsor of $150,000 under a promissory note. We repaid the promissory note in full on March 8, 2021. After closing the Initial Public Offering, our liquidity needs have been satisfied through the net proceeds from the consummation of the Initial Public Offering, the sale of Over-Allotment Units and the Private Placement held outside of the Trust Account, and from borrowings under a promissory note with our Sponsor. As of September 30, 2022, the company borrowed $450,000 from the sponsor under the Post-IPO Promissory Note for working capital purposes. The borrowings are reflected as Note payable-related party on the Consolidated Balance Sheets and are accounted for at fair value.

In connection with the Company’s assessment of going concern considerations in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 205-40, “Presentation of Financial Statements-Going Concern,” management has evaluated the Company’s liquidity and financial condition and determined that it may not be sufficient to meet the Company’s obligation over the period of twelve months from the issuance date of the financial statements. The Company’s sponsor has agreed to provide support to enable the Company to continue its operations and meet its potential obligations over a period of one year from the issuance of these financial statements. Management believes current working capital, and the support from its Sponsor, provides sufficient capital to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of these financial statements and therefore substantial doubt has been alleviated.

Management continues to evaluate the impact of macroeconomic and socioeconomic events (including increased benchmark interest rates, inflation impacts, and continuing effects from the COVID-19 pandemic) and has concluded that while it is reasonably possible that such events could have a negative effect on our financial position, results of our operations and/or search for a target company, the specific impact is not readily determinable as of the date of the condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of such uncertainties.

 

21


Table of Contents

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these condensed financial statements.

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any share redemption or other share repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent we would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. The mechanics of any required payment of the excise tax have not been determined. The foregoing uncertainties could cause a reduction in the cash available on hand to complete a Business Combination and may impact our ability to successfully complete a Business Combination.

Results of Operations

Our entire activity since inception up to September 30, 2022 related to our formation, the preparation for the Initial Public Offering, and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. We will not be generating any operating revenues until the closing and completion of our initial Business Combination.

For the three months ended September 30, 2022, we had net income of approximately $2.6 million, which consisted of a non-operating gain resulting from changes in fair value of derivative warrant liabilities of approximately $1.6 million and approximately $1.6 million of income from investments held in the Trust Account, partially offset by income tax expense of approximately $400,000 and a loss from operations of approximately $227,000 comprised of approximately $147,000 general and administrative expenses, approximately $30,000 in general and administrative expenses to a related party and approximately $50,000 of franchise tax expenses.

For the three months ended September 30, 2021, we had net income of approximately $3.2 million, which consisted of a non-operating gain resulting from a change in fair value of derivative warrant liabilities of approximately $3.6 million and approximately $6,000 of income from investments held in the Trust Account, partially offset by a loss from operations of approximately $433,000 comprised of approximately $353,000 general and administrative expenses, approximately $30,000 in general and administrative expenses to a related party and approximately $50,000 of franchise tax expenses.

For the nine months ended September 30, 2022, we had net income of approximately $9.5 million, which consisted of a non-operating gain resulting from changes in fair value of derivative warrant liabilities of approximately $8.6 million and approximately $2.0 million of income from investments held in the Trust Account, partially offset by income tax expense of approximately $452,000 and a loss from operations of approximately $701,000 comprised of approximately $494,000 general and administrative expenses, approximately $90,000 in general and administrative expenses to a related party and approximately $117,000 of franchise tax expenses.

 

22


Table of Contents

For the period from January 5, 2021 (inception) through September 30, 2021, we had net income of approximately $2.7 million, which consisted of a non-operating gain resulting from a change in fair value of derivative warrant liabilities of approximately $4.0 million and approximately $14,000 of income from investments held in the Trust Account, partially offset by a loss from operations of approximately $923,000 comprised of approximately $706,000 general and administrative expenses, approximately $69,000 in general and administrative expenses to a related party and approximately $147,000 of franchise tax expense, and a non-operating loss of approximately $424,000 for offering costs associated with derivative warrant liabilities.

Contractual Obligations

Administrative Services Agreement

Commencing on the date that our securities were first listed on Nasdaq through the earlier of consummation of the initial Business Combination and our liquidation, we agreed to pay an affiliate of the Sponsor a total of $10,000 per month for office space, administrative and support services.

The Sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. Our audit committee will review on a quarterly basis all payments that were made to the Sponsor, our directors, our officers or any of their affiliates.

We incurred approximately $30,000 and $30,000 in related party general and administrative expenses in the accompanying condensed statements of operations for the three months ended September 30, 2022 and 2021. We incurred approximately $90,000 and $69,000 in related party general and administrative expenses in the accompanying condensed statements of operations for the nine months ended September 30, 2022 and 2021.

Underwriting Agreement

We granted the underwriters a 45-day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price, less underwriting discounts and commissions. The underwriters exercised the over-allotment option in full and on March 16, 2021, purchasing an additional 4,500,000 Units.

The underwriters are entitled to an underwriting discount of $0.20 per Unit, or $6.9 million in the aggregate, paid upon the closing of the Initial Public Offering and sale of Over-Allotment Units. An additional fee of $0.35 per Unit, or approximately $12.1 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

Critical Accounting Policies

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. A summary of our significant accounting policies is included in Note 2 to our condensed financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q. Certain of our accounting policies are considered critical, as these policies are the most important to the depiction of our condensed financial statements and require significant, difficult or complex judgments, often employing the use of estimates about the effects of matters that are inherently uncertain. Such policies are summarized in the Management’s Discussion and Analysis of Financial Condition and Results of Operations section in our 2021 Annual Report on Form 10-K filed with the SEC on March 21, 2022. There have been no significant changes in the application of our critical accounting policies during the nine months ended September 30, 2022.

 

23


Table of Contents

Recent Accounting Pronouncements

See Note 2 to the unaudited condensed financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for a discussion of recent accounting pronouncements.

Off-Balance Sheet Arrangements

As of September 30, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

JOBS Act

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, the condensed financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were effective.

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

24


Table of Contents

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II-OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

Except as set forth below, as of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC on March 21, 2022. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

Under the Inflation Reduction Act of 2022, the Company may have liability for the 1% stock buyback tax to the extent holders of the Public Shares exercise their redemption rights.

On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022, which includes, among other provisions, a 1% excise tax on “repurchases of stock” by “covered corporations” beginning on January 1, 2023. A “covered corporation” is a domestic corporation that is traded on an established securities market. The Company would be considered a “covered corporation,” so “repurchases of stock” by the Company occurring after January 1, 2023 will be subject to the 1% excise tax (to the extent in excess of a $1 million annual threshold and subject to reduction for share issuances during the relevant year). It is possible that the 1% excise tax could apply to redemptions of Public Shares from holders exercising their redemption rights in connection with a Business Combination or if the Company redeems the Public Shares if the Company fails to complete a Business Combination within the Combination Period. Depending on the number of holders of Public Shares who exercise their redemption rights, the imposition of the 1% excise tax could potentially adversely affect the cash we have available for our operations following any Business Combination.

Changes in laws or regulations, or a failure to comply with any laws or regulations, may adversely affect our business, investments and results of operations.

We are subject to laws and regulations enacted by national, regional and local governments. In particular, we are required to comply with certain SEC and other legal requirements. Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete an initial business combination, and results of operations.

On March 30, 2022, the SEC issued proposed rules relating to, among other items, enhancing disclosures in business combination transactions involving SPACs and private operating companies; amending the financial statement requirements applicable to transactions involving shell companies; and increasing the potential liability of certain participants in proposed business combination transactions. These rules, if adopted, whether in the form proposed or in revised form, may materially adversely affect our ability to negotiate and complete our initial business combination and may increase the costs and time related thereto.

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing

 

25


Table of Contents

corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any share redemption or other share repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent we would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. The mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in our ability to complete a Business Combination.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities.

Simultaneous with the closing of the Initial Public Offering, the Company consummated the Private Placement of 5,333,333 Private Placement Warrants at a price of $1.50 per Private Placement Warrant to the Sponsor, generating proceeds of $8.0 million. Simultaneous with the closing of the Over-Allotment Units on March 16, 2021, the Company consummated the second closing of the Private Placement, resulting in the purchase of an additional 600,000 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of $900,000. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

In connection with the Initial Public Offering, our Sponsor had agreed to loan us an aggregate of up to $300,000 pursuant to a promissory note. This loan is non-interest bearing and payable on the consummation of the Initial Public Offering. We borrowed an aggregate of $150,000 under the promissory note and repaid the promissory note in full on March 8, 2021.

Of the gross proceeds received from the Initial Public Offering and the full exercise of the option to purchase additional Shares, $345,000,000 was placed in the Trust Account. The net proceeds of the Initial Public Offering, the sale of Over-Allotment Units and certain proceeds from the Private Placement are invested in U.S. government treasury bills with a maturity of 180 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations.

We paid a total of approximately $6.9 million in underwriting discounts and commissions related to the Initial Public Offering and the sale of Over-Allotment Units. In addition, the underwriters agreed to defer approximately $12.1 million in underwriting discounts and commissions.

Item 3. Defaults upon Senior Securities

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

 

26


Table of Contents

Item 6. Exhibits.

 

Exhibit

Number

   Description
10.1    Promissory Note, dated as of May 10, 2022 by and between the Company and the Sponsor
31.1*    Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*    Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*    Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*    Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS    Inline XBRL Instance Document
101.SCH    Inline XBRL Taxonomy Extension Schema Document
101.CAL    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB    Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE    Inline XBRL Taxonomy Extension Presentation Linkbase Document
104    Cover page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

*

These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

 

27


Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 9, 2022     RXR ACQUISITION CORP.
    By:  

/s/ Scott Rechler

    Name:   Scott Rechler
    Title:   Chief Executive Officer and Chairman

 

28